A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities

Zhang,Hongqi; Chu,Ge; Pan,Chao; Hu,Jianzhong; Guo,Chaofeng; Liu,Jinyang; Wang,Yuxiang; Wu,Jianhuang

doi:10.3892/etm.2014.2021

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities

Authors:
- Hongqi Zhang
- Ge Chu
- Chao Pan
- Jianzhong Hu
- Chaofeng Guo
- Jinyang Liu
- Yuxiang Wang
- Jianhuang Wu
View Affiliations

Affiliations: Department of Spine Surgery, Xiangya Spinal Surgery Center, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China
Published online on: October 15, 2014 https://doi.org/10.3892/etm.2014.2021
Pages: 1835-1840

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study aimed to determine whether a novel nutrient mixture (NM), composed of lysine, ascorbic acid, proline, green tea extracts and other micronutrients, attenuates impairments induced by spinal cord injury (SCI) and to investigate the related molecular mechanisms. A mouse model of SCI was established. Thirty-two mice were divided into four groups. The sham group received vehicle only. The SCI groups were treated orally with saline (saline group), a low dose (500 µg 3 times/day) of NM (NM-LD group) or a high dose (2,000 µg 3 times/day) of NM (NM-HD group). The levels of mouse hindlimb movement were determined every day in the first week post-surgery. The protein expression levels of matrix metalloproteinase (MMP)-2 and MMP-9 were determined by western blotting. Wild-type and mutant MMP-2- and MMP-9-directed luciferase constructs were generated and their luciferase activities were determined. NM significantly facilitated the recovery of hindlimb movement of the mice in comparison to that in the saline group. The expression levels of MMP-2 in the NM-LD and NM-HD groups were decreased by ~50% compared with the saline group as indicated by western blotting results. The expression levels of MMP-9 in the NM-LD and NM-HD groups were decreased to ~25 and ~10%, respectively. These results suggest that NM significantly inhibits the expression of MMP-2 and MMP-9 proteins. Reverse transcription quantitative polymerase chain reaction results indicated that NM reduced the levels of MMP-2 and MMP-9 mRNA. Furthermore, the luciferase results indicated that site‑directed mutagenesis comprising a -1306 C to T (C/T) base change in the MMP-2 promoter and a -1562 C/T base change in the MMP-9 promoter abolished the inhibitory effects of NM on MMP-2 and MMP-9 promoters. These results suggest that NM attenuates SCI-induced impairments in mice movement by negatively affecting the promoter activity of MMP-2 and MMP-9 genes and thus decreasing the expression of MMP-2 and MMP-9 proteins.

View Figures

View References

1	Kenney K and Diaz-Arrastia R: Review of traumatic brain and spinal cord injury: challenges and developments. JAMA Neurol. 70:13332013. View Article : Google Scholar
2	Neirinckx V, Cantinieaux D, Coste C, et al: Spinal cord injuries - how could adult mesenchymal and neural crest stem cells take up the challenge? Stem Cells. 32:829–843. 2014. View Article : Google Scholar : PubMed/NCBI
3	Papa S, Rossi F, Ferrari R, et al: Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury. ACS Nano. 7:9881–9895. 2013. View Article : Google Scholar : PubMed/NCBI
4	Nelissen S, Vangansewinkel T, Geurts N, et al: Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4. Neurobiol Dis. 62:260–272. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ahmad FU, Wang MY and Levi AD: Hypothermia for acute spinal cord injury - a review. World Neurosurg. 82:207–214. 2014. View Article : Google Scholar : PubMed/NCBI
6	Yamamoto A, Matsubara K, Kano F and Sakai K: Analysis of the neuroregenerative activities of mesenchymal stem cells in functional recovery after rat spinal cord injury. Methods Mol Biol. 1213:321–328. 2014. View Article : Google Scholar : PubMed/NCBI
7	Bareyre FM and Schwab ME: Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci. 26:555–563. 2003. View Article : Google Scholar : PubMed/NCBI
8	DeWitt DS, Prough DS, Taylor CL and Whitley JM: Reduced cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and mild hemorrhage in cats. J Neurosurg. 76:812–821. 1992. View Article : Google Scholar : PubMed/NCBI
9	Kruman II and Mattson MP: Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J Neurochem. 72:529–540. 1999. View Article : Google Scholar : PubMed/NCBI
10	Pedersen MO, Jensen R, Pedersen DS, et al: Metallothionein-I+II in neuroprotection. Biofactors. 35:315–325. 2009. View Article : Google Scholar : PubMed/NCBI
11	Takahashi H, Manaka S and Sano K: Changes in extracellular potassium concentration in cortex and brain stem during the acute phase of experimental closed head injury. J Neurosurg. 55:708–717. 1981. View Article : Google Scholar : PubMed/NCBI
12	Yamakami I and McIntosh TK: Effects of traumatic brain injury on regional cerebral blood flow in rats as measured with radiolabeled microspheres. J Cereb Blood Flow Metab. 9:117–124. 1989. View Article : Google Scholar : PubMed/NCBI
13	Zemper ED: Analysis of cerebral concussion frequency with the most commonly used models of football helmets. J Athl Train. 29:44–50. 1994.PubMed/NCBI
14	Lau BY, Fogerson SM, Walsh RB and Morgan JR: Cyclic AMP promotes axon regeneration, lesion repair and neuronal survival in lampreys after spinal cord injury. Exp Neurol. 250:31–42. 2013. View Article : Google Scholar : PubMed/NCBI
15	Nakano N, Nakai Y, Seo TB, et al: Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats. PLoS One. 8:e734942013. View Article : Google Scholar : PubMed/NCBI
16	Liotta LA, Tryggvason K, Garbisa A, et al: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284:67–68. 1980. View Article : Google Scholar : PubMed/NCBI
17	Stetler-Stevenson WG: The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am. 10:383–392. 2001.PubMed/NCBI
18	Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303. 1990. View Article : Google Scholar : PubMed/NCBI
19	Vlodavsky E, Palzur E and Soustiel JF: Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury. Neuropathol Appl Neurobiol. 32:40–50. 2006. View Article : Google Scholar : PubMed/NCBI
20	Hansen CN, Fisher LC, Deibert RJ, et al: Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in mice. J Neurosci. 33:13101–13111. 2013. View Article : Google Scholar : PubMed/NCBI
21	Miao X, Yu C, Tan W, et al: A functional polymorphism in the matrix metalloproteinase-2 gene promoter (−1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res. 63:3987–3990. 2003.
22	Markiewicz L, Majsterek I, Przybylowska K, et al: Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma. Acta Ophthalmol. 91:e516–e523. 2013.PubMed/NCBI
23	Roomi MW, Kalinovsky T, Niedzwiecki A and Rath M: Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines. Int J Oncol. 43:1027–1035. 2013.
24	Basso DM, Fisher LC, Anderson AJ, et al: Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 23:635–659. 2006. View Article : Google Scholar : PubMed/NCBI
25	Kankaanranta H, Ilmarinen P, Zhang X, et al: Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1. PLoS One. 9:e902982014.
26	Tang M, Shi S, Guo Y, et al: GSK-3/CREB pathway involved in the gx-50’s effect on Alzheimer’s disease. Neuropharmacology. 81:256–266. 2014.PubMed/NCBI